<DOC>
	<DOCNO>NCT00770861</DOCNO>
	<brief_summary>This study evaluate efficacy safety nebivolol monotherapy Hispanic patient stage 1 stage 2 hypertension</brief_summary>
	<brief_title>A Study Efficacy Safety Nebivolol Monotherapy Hispanic Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Male female outpatient 18 80 year age , selfidentified Hispanic Latino ethnicity Females must postmenopausal , pregnant use approved contraceptive regimen Meet criterion stage I II hypertension Currently treat , treat two antihypertensive medication Secondary hypertension Are take three antihypertensive agent Have uncontrolled poorly control diabetes mellitus type I type II Evidence concurrent disease condition might interfere conduct study Participation investigational study within 30 day Screening ( Visit 1 ) . Have history hypersensitivity nebivolol βblockers , contraindication βblocker use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>nebivolol</keyword>
	<keyword>Bystolic ™</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hispanic</keyword>
	<keyword>Hypertension Hispanic patient</keyword>
</DOC>